Literature DB >> 17444624

Synthesis, DNA binding, and Leishmania topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives.

Padmaparna Chaudhuri1, Hemanta K Majumder, Santanu Bhattacharya.   

Abstract

Nine novel anthra[1,2-d]imidazole-6,11-diones, differing in their side chain, were synthesized. UV-vis spectroscopy and viscometric titrations of these molecules with duplex DNA were used to assess their binding with DNA. Five of the nine compounds showed high inhibition activity against topoisomerase I of Leishmania donovani, with the one bearing the tetrazole side chain exhibiting an IC50 approximately 1 microM. The inhibition activities were not related with their DNA binding affinity and depended on the nature of the side chain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444624     DOI: 10.1021/jm0610604

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents.

Authors:  Anuradha Seth; Anirban Ghoshal; Varun Dewaker; Ankita Rani; Sangh Priya Singh; Mukul Dutta; Shivani Katiyar; Sandeep Kumar Singh; Mamunur Rashid; Muhammad Wahajuddin; Susanta Kar; Ajay Kumar Srivastava
Journal:  RSC Med Chem       Date:  2022-05-11

2.  Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

Authors:  Ananya Paul; Akash K Jain; Santosh K Misra; Basudeb Maji; K Muniyappa; Santanu Bhattacharya
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

3.  Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors.

Authors:  Rajinikanth Mamidala; Papiya Majumdar; Kunal Kumar Jha; Chandramohan Bathula; Rahul Agarwal; M Thirumala Chary; Hemanta K Majumder; Parthapratim Munshi; Subhabrata Sen
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.